 Connection
Whitney High to Melanoma
This is a "connection" page, showing publications Whitney High has written about Melanoma.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.394 |
|
|
|
-
Dinehart MS, Dinehart SM, Sukpraprut-Braaten S, High WA. Immunohistochemistry utilization in the diagnosis of melanoma. J Cutan Pathol. 2020 May; 47(5):446-450.
Score: 0.438
-
High WA. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma. Dermatol Clin. 2017 Oct; 35(4):525-536.
Score: 0.369
-
Suarez A, High WA. Immunohistochemical analysis of KBA.62 in 18 neurothekeomas: a potential marker for differentiating neurothekeoma, but a marker that may lead to confusion with melanocytic tumors. J Cutan Pathol. 2014 Jan; 41(1):36-41.
Score: 0.288
-
Marsch A, High WA. Medicolegal issues with regard to melanoma and pigmented lesions in dermatopathology. Dermatol Clin. 2012 Oct; 30(4):593-615, v-vi.
Score: 0.262
-
High WA. Malpractice in dermatopathology: principles, risk mitigation, and opportunities for improved care for the histologic diagnosis of melanoma and pigmented lesions. Clin Lab Med. 2008 Jun; 28(2):261-84, vii.
Score: 0.195
-
High WA, Robinson WA. Genetic mutations involved in melanoma: a summary of our current understanding. Adv Dermatol. 2007; 23:61-79.
Score: 0.177
-
High WA, Stewart D, Wilbers CR, Cockerell CJ, Hoang MP, Fitzpatrick JE. Completely regressed primary cutaneous malignant melanoma with nodal and/or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria. J Am Acad Dermatol. 2005 Jul; 53(1):89-100.
Score: 0.160
-
High WA, Quirey RA, Guill?n DR, Mun?z G, Taylor RS. Presentation, histopathologic findings, and clinical outcomes in 7 cases of melanoma in situ of the nail unit. Arch Dermatol. 2004 Sep; 140(9):1102-6.
Score: 0.151
-
Clarke LE, Mabey B, Flake Ii DD, Meek S, Cassarino DS, Duncan LM, High WA, Napekoski KM, Prieto VG, Tetzlaff MT, Vitale P, Elder DE. Clinical validity of a gene expression signature in diagnostically uncertain neoplasms. Per Med. 2020 09; 17(5):361-371.
Score: 0.113
-
Winkelmann RR, Farberg AS, Glazer AM, Cockerell CJ, Sober AJ, Siegel DM, Leachman SA, High WA, Markowitz O, Berman B, Pariser DM, Goldenberg G, Rosen T, Rigel DS. Integrating Skin Cancer-Related Technologies into Clinical Practice. Dermatol Clin. 2017 Oct; 35(4):565-576.
Score: 0.092
-
Good LM, Miller MD, High WA. Intralesional agents in the management of cutaneous malignancy: a review. J Am Acad Dermatol. 2011 Feb; 64(2):413-22.
Score: 0.055
-
Fujita M, High WA, Asgari S, Lewis KD, Gonzalez R. Development of vitiligo during melanoma treatment with a novel survivin inhibitor: a case report and review of the literature. Int J Dermatol. 2009 Apr; 48(4):426-30.
Score: 0.052
-
Lewis KD, Dollarhide S, Fitzpatrick JE, Gonzalez R, High WA, McCarter MD, Olsen C, Raben D. Metastatic malignant melanoma from an unknown primary presenting as a large axillary mass. Oncology (Williston Park). 2006 Jun; 20(7):763-70.
Score: 0.043
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|